Thioltransferase overexpression increases resistance of MCF-7 cells to adriamycin

Free Radical Biology and Medicine

Volumn 26, Issue 5-6, 1999, Pages 770-776

  Meyer, Elizabeta B ^a   Wells, William W ^a  

^a Michigan State University   (United States)

Author keywords

Adriamycin; Ascorbic acid; Free radicals; MCF 7 human breast tumor cells; Reactive oxygen species; Thioltransferase

Indexed keywords

ASCORBIC ACID; COMPLEMENTARY DNA; DOXORUBICIN; FREE RADICAL; THIOLTRANSFERASE; TRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG TARGETING; ENZYME ACTIVITY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL SURVIVAL; DNA, COMPLEMENTARY; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; OXIDOREDUCTASES; PLACENTA; PREGNANCY; PROTEIN DISULFIDE REDUCTASE (GLUTATHIONE); RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0033048005     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00247-0     Document Type: Article

References (45)

1. Wells W.W., Yang Y., Deits T.L., Gan Z.-R. Thioltransferases. Meister A. Advances in enzymology and related areas of molecular biology. 1992;149-201 John Wiley & Sons, Inc, New York.
2. Wells W.W., Xu D.P., Yang Y., Rocque P.A. Mammalian thioltransferase (glutaredoxin) and protein disulfide isomerase have dehydroascorbate reductase activity. J. Biol. Chem. 265:1990;15361-15364.
3. Mieyal J.J., Gravina S., Mieyal P.A., Srinivasan U., Starke D.W. Glutathionyl specificity of thioltransferses Mechanistic and physiological implications . Packer L., Cadenas E. Biothiols in health and disease. 1995;305-372 Marcel Dekker, Inc, New York.
4. Meister A. On the antioxidant effects of ascorbic acid and glutathione. Biochem. Pharm. 44:1992;1905-1915.
5. Axelsson K., Mannervik B. An essential role of cytosolic thioltransferase in protection of pyruvate kinase from rabbit liver against oxidative inactivation. FEBS Lett. 152:1983;114-118.
6. Kersten H., Kersten W., Staudinger H. Zum wirkungsmechanismus der ascorbinsäure I. Isolierung einer ascorbinsäureabhängigen DPNH-oxidase aus nebennierenmikrosomen. [On the action mechanism of ascorbic acid I. Isolation of an ascorbic acid dependent DPNH-oxidase from adrenal micosomes]. Biochim. Biophys. Acta. 27:1958;598-608.
7. Park J.B., Levine M. Purification, cloning and expression of dehydroascorbic acid-reducing activity from human neutrophils Identification as glutaredoxin . Biochem. J. 315:1996;931-938.
8. Chai Y.-C., Hendrich S., Thomas J.A. Protein S-thiolation in hepatocytes stimulated by t-butyl hydroperoxide, menadione, and neutrophils. Arch. Biochem. Biophys. 310:1994;264-272.
9. Chai Y.C., Jung C.-H., Lii C.K., Ashraf S.S., Hendrich S., Wolf B., Sies H., Thomas J.A. Identification of an abundant S-thiolated rat liver protein as carbonic anhydrase III characterization of S-thiolation and dethiolation reactions . Arch. Biochem. Biophys. 284:1991;270-278.
10. Schuppe-Koinstein I., Gerdes R., Moldeus P., Cotgreave I.A. Studies on the reversibility of protein S-thiolation in human endothelial cells. Arch. Biochem. Biophys. 315:1994;226-234.
11. Srinivasan U., Mieyal P.A., Mieyal J.J. pH profiles indicative of rate-limiting nucleophilic displacement in thioltransferase catalysis. Biochemistry. 36:1997;3199-3206.
12. Halliwell, B. Free radicals, ageing and disease. In: Halliwell, B.; Gutteridge, J. M. C., eds. Free radicals in biology and medicine, 2nd edn. New York: Oxford University Press; 1995:489-492.
13. Tormey D.C., Simon R., Falkson G., Bull J., Band P., Perlin E., Blom J. Evaluation of adriamycin and dibromodulcitol in metastatic breast carcinomas. Cancer Res. 37:1977;529-534.
14. Pigram W.J., Fuller W., Hamilton L.D. Sterochemistry of intercalation interaction of daunomycin with DNA . Nature New Biol. 235:1972;17-19.
15. Pommier Y., Schwartz R.E., Zwelling L.A., Kohn K.W. Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei. Cancer Res. 24:1985;6406-6410.
16. Tritton T.R., Yee G. The anticancer drug Adriamycin can be actively cytotoxic without entering cells. Science. 217:1982;248-250.
17. Thayer W.S. Adriamycin stimulated superoxide formation in submitochondrial particles. Chem. Biol. Interact. 19:1977;265-278.
18. Davies K.J.A., Doroshow J.H. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J. Biol. Chem. 261:1986;3060-3067.
19. Doroshow J.H., Davies K.J.A. Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J. Biol. Chem. 261:1986;3068-3074.
20. Coley H.M., Twentyman P.R., Workman P. Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A. Biochem. Pharmacol. 38:1989;4467-4475.
21. Simon S.M., Roy D., Schindler M.S. Intracellular pH and the control of multidrug resistance. Proc. Natl. Acad. Sci. USA. 91:1994;1128-1132.
22. Mimnaugh E.G., Dusre L., Atwell J., Myers C.E. Differential oxygen radical susceptibility of Adriamycin-sensitive MCF-7 human breast tumor cells. Cancer Res. 49:1989;8-15.
23. Gill D.R., Hyde S.C., Higgins C.F., Valverde M.A., Mintenig G.M., Sepulveda F.V. Separation of drug transport and chloride channel functions of human multidrug resistance P-glycoprotein. Cell. 71:1992;23-32.
24. Akman S.A., Forrest G., Chu F.-F., Esworthy S., Doroshow J. Antioxidant and xenobiotic-metabolizing enzyme gene expression in Doxorubicin-resistant MCF-7 breast cancer cells. Cancer Res. 50:1990;1397-1402.
25. Batist G., Tulpule A., Sinha B.K., Katki A.G., Myers C.E., Cowan K.H. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem. 261:1986;15544-15549.
26. Fairchild C.R., Ivy S.P., Chien-Song K.S., Whang-Peng J., Rosen N., Israel M.A., Melera P.W., Cowan K.H., Goldsmith M.E. Isolation of amplified and oxerexpressed DNA sequences from Adriamycin-resistant human breast cancer cells. Cancer Res. 47:1987;5141-5148.
27. Ivy S.P., Tulpule A., Fairchild C.R., Auerbach S.D., Myers C.E., Nebest D.W., Baird W.M., Cowan K.H. Altered regulation of P-450IA1 expression in a multi-drug resistant MCF-7 human breast cell cancer line. J. Biol. Chem. 263:1988;19119-19125.
28. Simon S.M., Roy D., Schindler M.S. Intracellular pH and the control of multidrug resistance. Proc. Natl. Acad. Sci. USA. 91:1994;1128-1132.
29. Moscow J.A., Townsend A.J., Cowan K.H. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST-pi gene and its effect on sensitivity to toxins. Mol. Pharm. 36:1989;22-28.
30. Townsend A.J., Tu C.-P.D., Cowan K.H. Expression of human μ and α class glutathione S-transferases in stably transfected human breast cancer cells effect on cellular sensitivity to cytotoxic agents . Mol. Pharm. 41:1992;230-236.
31. Wells W.W., Rocque P.A., Xu D.-P., Meyer E.B., Charamella L.J., Dimitrov N.V. Ascorbic acid and cell survival of adriamycin resistant and sensitive MCF-7 breast tumor cells. Free Radic. Biol. Med. 18:1995;699-708.
32. Schmidt E., Christoph G., Zeller R., Leder P. The cytomegalovirus enhancer a pan-active control element in transgenic mice . Mol. Cell Biol. 10:1990;4406-4411.
33. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
34. Kawasaki, E. Amplification of RNA. In: Innis, M. A.; Gelfand, D. H.; Sninsky, J. J.; White, T.J., eds. PCR protocols. San Diego: Academic Press; 1990:21-27.
35. Gan Z.-R., Wells W.W. Identification and reactivity of the catalytic site of pig liver thioltransferase. J. Biol. Chem. 262:1987;6704-6707.
36. Segle J.H., Johnson M.J. Synthesis and characterization of sodium cysteine-S-sulfate monohydrate. Anal. Biochem. 5:1963;330-337.
37. Brown R.E., Jarvis K.L., Hyland K.J. Protein measurement using bicinchoninic acid elimination of interfering substances . Anal. Biochem. 180:1989;136-139.
38. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
39. Terada T., Oshida T., Nishimura M., Maeda H., Hara T., Hosomi S., Mizoguchi T., Nishihara T. Study on human erythrocyte thioltransferase Comparative characterization with bovine enzyme and its physiological role under oxidative stress . J. Biochem. Tokyo. 111:1992;688-692.
40. Doroshow J., Esworthy S., Burke T., Chu F.-F., Akman S. Doxorubicin resistance conferred by selective enhancement of intracellular glutathione peroxidase or superoxide dismutase content in human MCF-7 breast cancer cells. Free Radic. Res. Commun. 12-13:1991;779-781.
41. Yoshitake S., Nanri H., Fernando M.R., Minakami S. Possible differences in regenerative roles played by thioltransferase and thioredoxin for oxidatively damaged proteins. J. Biochem. 166:1994;42-46.
42. Yokimozo A., Ono M., Nanri H., Makino Y., Ohga T., Wada M., Okamoto T., Yodoi J., Kuwano M., Kohno K. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res. 55:1995;4293-4296.
43. Gallegos A., Gasdaska J.R., Taylor C.W., Paine-Murrieta G.D., Goodman D., Gasdaska P.Y., Berggren M., Briehl M.M., Powis G. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res. 56:1996;5765-5770.
44. Rosen C.F., Poon R., Drucker D.J. UVB radiation-activated genes induced by transcription of and posttranslational mechanisms in rat keratinoctyes. Am. J. Physiol. 268:1995;C846-C855.
45. Meyer E.B., Wells W.W. Cloning, sequencing and expression of human placental thioltransferase. FASEB J. 9:1995;1195. abstr.